Cenegenics integrates Human Sync to expand longevity care

Cenegenics said June 25 it is integrating Human Sync’s clinical practice and protocols to strengthen its physician-led longevity and performance medicine model. The move brings Human Sync co-founder Erik Nelson into Cenegenics’ clinical leadership team as the company pushes for more personalized preventive care.

Why it matters: - The integration expands Cenegenics’ clinical capabilities in longevity, preventive and performance medicine. - The deal is aimed at preserving a physician-led, relationship-driven model while adding Human Sync’s continuous care approach. - Cenegenics is betting that measurable outcomes and ongoing physician guidance will matter more as longevity medicine grows.

What happened: - Cenegenics said June 25, 2026, that it is integrating the clinical practice of Human Sync. - Human Sync’s clinical team and evidence-based protocols are joining Cenegenics. - Human Sync co-founder Erik Nelson will join Cenegenics’ clinical leadership team. - Brad Pierce, founder and CEO of Human Sync, said the practice was built around the idea that testing starts the process and the relationship is the product.

The details: - Human Sync was built by a Mayo Clinic-trained clinical team. - Human Sync was designed for top executives and high-net-worth individuals. - The Human Sync model uses a “Chief Health Officer” approach. - The model gives each client a continuous, physician-led relationship instead of a one-time diagnostic workup. - Human Sync turns comprehensive testing into an ongoing, personalized plan with continuous physician guidance. - Cenegenics said the integration will strengthen its approach to personalized performance health, longevity and preventive medicine. - Cenegenics describes itself as the pioneer and global leader in physician-led performance health and longevity medicine. - Cenegenics says it has operated for nearly 30 years and across five continents since 1997. - Cenegenics says its model combines advanced diagnostics, precision medicine, AI-informed insights, evidence-based protocols and personalized coaching. - Cenegenics says its approach is designed to improve healthspan, performance and health outcomes. - A contact listed in the release is Jason Ozols at Cenegenics, +1 702-992-1213. - The release includes social links for Instagram, YouTube, LinkedIn, Facebook and TikTok.

Between the lines: - The move suggests Cenegenics wants to scale a more continuous, concierge-style care model for affluent clients. - The addition of Human Sync’s team signals a focus on combining diagnostics with long-term physician oversight. - Graham Galka, CEO of Cenegenics, said organizations that can demonstrate real clinical outcomes and trust at scale will define the next phase of longevity medicine. - The deal also reinforces Cenegenics’ effort to compete on clinical credibility rather than branding alone.

What's next: - Cenegenics will fold Human Sync’s protocols and clinical expertise into its broader platform. - Erik Nelson’s role on Cenegenics’ clinical leadership team could shape how the combined practice delivers personalized care. - The company will likely use the integration to deepen its prevention and optimization offerings for members.

The bottom line: - Cenegenics is using the Human Sync integration to broaden its longevity platform while doubling down on physician-led, outcome-focused care.